Towa Pharmaceutical , Ltd. Profit Margin

Towa Pharmaceutical , Ltd. (4553.T) currently reports a profit margin of 2.93% as of June 2026. That compares with 6.1% in the prior-year period — down 51.9% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Towa Pharmaceutical , Ltd.'s profit margin history and peer comparisons.

Towa Pharmaceutical , Ltd.'s profit margin decreased from 6.1% to 2.93% — a 51.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Towa Pharmaceutical , Ltd.'s profit margin of 2.93% is lower than the its sector sector average of 13.23%. That is roughly 77.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Towa Pharmaceutical , Ltd.'s current 2.93% should be judged against industry norms (sector average: 13.23%) and against 4553.T's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 2.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Towa Pharmaceutical , Ltd., and consider following 4553.T for alerts when major investors trade the stock.